CAS:869884-78-6
869884-78-6
CAS号：869884-78-6
品名：雷得唑来Radezolid
中文别名：N-[[(5S)-3-[2-氟-4'-[[(1H-1,2,3-三唑-5-基甲基)氨基]甲基][1,1'-联苯]-4-基]-2-氧代-5-恶唑啉基]甲基]乙酰胺;
英文别名：RX-1741;RX-103;UNII-53PC6LO35W;Acetamide,N-[[(5S)-3-[2-fluoro-4'-[[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl][1,1'-biphenyl]-4-yl]-2-oxo-5-oxazolidinyl]methyl]-;N-[[(5S)-3-[3-fluoro-4-[4-[(2H-triazol-4-ylmethylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide;
分子式：C22H23FN6O3
分子量：438.455
精确质量：438.182
Psa：112.24
MDL号：MFCD22628873
外观与性状：白色至米黄色固体
密度：1.336g/cm3
简介：Radezolid(INN,codenamedRX-1741)isanoveloxazolidinoneantibioticbeingdevelopedbyMelintaTherapeutics,Inc.forthetreatmentofseriousmulti-drug–resistantinfections.Radezolidhascompletedtwophase-IIclinicaltrials.Oneoftheseclinicaltrialswasforuncomplicatedskinandskin-structureinfections(uSSSI)andtheotherclinicaltrialwasforcommunityacquiredpneumonia(CAP).
微生物Microbiology
